Cargando…

Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia

A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Xu Cong, Tan, Poh Yong, Tan, Yuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679710/
https://www.ncbi.nlm.nih.gov/pubmed/31396468
http://dx.doi.org/10.7759/cureus.4800
_version_ 1783441393272750080
author Ruan, Xu Cong
Tan, Poh Yong
Tan, Yuyang
author_facet Ruan, Xu Cong
Tan, Poh Yong
Tan, Yuyang
author_sort Ruan, Xu Cong
collection PubMed
description A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in the primary care setting to reduce medication-related hospitalizations.
format Online
Article
Text
id pubmed-6679710
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-66797102019-08-08 Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia Ruan, Xu Cong Tan, Poh Yong Tan, Yuyang Cureus Endocrinology/Diabetes/Metabolism A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in the primary care setting to reduce medication-related hospitalizations. Cureus 2019-06-02 /pmc/articles/PMC6679710/ /pubmed/31396468 http://dx.doi.org/10.7759/cureus.4800 Text en Copyright © 2019, Ruan et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Ruan, Xu Cong
Tan, Poh Yong
Tan, Yuyang
Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title_full Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title_fullStr Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title_full_unstemmed Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title_short Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
title_sort clarithromycin and glipizide drug-drug interaction leading to refractory hypoglycemia
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679710/
https://www.ncbi.nlm.nih.gov/pubmed/31396468
http://dx.doi.org/10.7759/cureus.4800
work_keys_str_mv AT ruanxucong clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia
AT tanpohyong clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia
AT tanyuyang clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia